3Liang X,Bi S,Yang W,et al.Epidemiological serosurvey of B in China-declining HBV Prevalence due to hepatitis B vaccination[J].Vaccine,2009,27(47):6550-6557.
4Elefsiniotis IS,Tsoumakas K,Papadakis M,et al.Importance of maternal and cord blood viremia in pregnant women with chronic hepatitis B virus infection[J].Eur J Intern Med,2011,22(2):182-186.
8Han GR,Cao MK,Zhao W,et al.A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection[J].J Herpetology,2011,55(6):1215-1221.
6ZHANG Q, SUN L R. Selective inhibitors of hepartitis B virusreplication [J].中国药学杂志,2006,41(16):1205-1209.
7Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. The guideline of preven- tion and treatment for chronic hepatitis B[ J]. 中国肝病杂志,2005,13(12):881-891.
8Chinese Society of Hepatology, Chinese Medical AssociationChi- nese Society of Infectious Diseases, Chinese Medical Association. The Guideline of Prevention and Treatment for Chronic HepatitisB(慢性乙型肝炎防治指南)[M].2010:1-12.
9CHEN X Q,JIN Y Y,TANG G. New Materia Medica(新编药物学)[M].Section 17 version, Beijing: People's Health PublishingHouse ,2011 : 128-130.
10LI L, LI Y Z. New drug of anti-hepatitis B virus-entecavir [ J].新药与临床,2006,4(4):56.
